President
Dr Ben Othmane brings extensive experience working at research centers, universities, and companies in several countries, including the USA, Canada, and Germany, from software development and management, cyber-security, and artificial intelligence research and development projects.
Board Member
Dr. Johansen has experience in biotech startup companies engaged in developing molecular diagnostics and the development of drug lead compounds using a proprietary molecular evolution method. She has provided support for commercialization and business development efforts for over 300 startup and early stage companies in a wide variety of technology domains.
Board Member
Mr. Neugent is an accomplished, hands-on manager with broad domestic international experience. He has been the President of a number of firms, including a publicly-traded company and many licensing businesses, and retains strong sales, marketing, operations and public relations experience.